Chlamydia is a major bacterial pathogen that infects humans, as well as a wide range of
animals, including marsupials, birds, cats, pigs, cattle, and sheep. Antibiotics are the only …

Attempts to produce a vaccine to protect against Chlamydia trachomatis-induced trachoma
were initiated more than 100 years ago and continued for several decades. Using whole …

Chlamydia trachomatis is the leading cause of bacterial sexually transmitted disease
worldwide, and despite significant advances in chlamydial research, a prophylactic vaccine …

Chlamydia trachomatis (Ct), an obligate intracellular parasite, is the leading cause of
bacterial sexually transmitted diseases worldwide. The best solution to control the spread of …

Chlamydia trachomatis genital infection is a worldwide public health problem, and
considerable effort has been expended on developing an efficacious vaccine. The murine …

Despite effective antimicrobial chemotherapy, control of Chlamydia trachomatis urogenital
infection will likely require a vaccine. We have assessed the protective effect of an outer …

Engineered outer membrane vesicles (OMVs) derived from Gram-negative bacteria are a
promising technology for the creation of non-infectious, nanoparticle vaccines against …

Ocular and urogenital infections with Chlamydia trachomatis (Ct.) are caused by a range of
different serovars. The first Ct. vaccine in clinical development (CTH522/CAF® 01) induced …

Chlamydia trachomatis is the etiological agent of the most commonly reported bacterial
sexual transmitted infection (STI) in North America and Europe. The control of Chlamydia …

Chlamydial infections represent a major threat to the long-term survival of the koala and a
successful vaccine would provide a valuable management tool. Vaccination however has …